日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Outcomes of a prospective cohort study of PREoperative therapy and supportive care in early & locally advanced breast cancers-PreSCella study

一项关于早期和局部晚期乳腺癌术前治疗和支持性护理的前瞻性队列研究的结果——PreSCella 研究

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-026-00898-0
Lee, Han Yi; Ong, Whee Sze; Tan, Jasmine Yun Ting; Ma, Jun; Zhang, Zewen; Tan, Si Ying; Yang, Grace Meijuan; Teo, Irene; Goh, Wei Lin; Tan, Mabel May Leng; Yap, Yoon Sim; Chan, Jack Junjie; Tan, Ryan Shea Ying Cong; Tan, Wu Meng; Lim, Elaine; Sivaraj, Huren; Beh, Sok Yuen; Soh, Lay Tin; Chay, Wen Yee; Dent, Rebecca; Kanesvaran, Ravindran; Wong, Mabel; Tan, Benita Kiat Tee; Wong, Fuh Yong; Tan, Kiak Mien Veronique; Tan, Tira J
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The 'HERBAL' Trial

使用传统中医治疗乳腺癌和其他癌症幸存者因癌症引起的疲劳和相关认知症状而导致的健康相关生活质量干预：‘草药’试验

期刊:Integrative Cancer Therapies
影响因子:2.8
doi:10.1177/15347354251314514
Chan, Alexandre; Chan, Daniella; Ng, Ding Quan; Zheng, Huang Fang; Tan, Quan Ming; Tan, Chia Jie; Toh, Jolene Hui Min; Yap, Ning Yi; Toh, Yi Long; Ke, Yu; Wang, Edmund Chun Ann; Lim, Queenie Pei Ni; Ho, Han Kiat; Chew, Lita; Tan, Tira J
神经科学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer

DORA II期研究：奥拉帕尼联合或不联合度伐利尤单抗作为铂类预处理晚期三阴性乳腺癌患者无化疗维持治疗策略的疗效

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-2513
Tan, Tira J; Sammons, Sarah; Im, Young-Hyuck; She, Lilin; Mundy, Kelly; Bigelow, Robert; Traina, Tiffany A; Anders, Carey; Yeong, Joe; Renzulli, Ezequiel; Kim, Sung-Bae; Dent, Rebecca
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

ENABLE-SG (Educate, Nurture, Advise, Before Life Ends for Singapore) as a proactive palliative care model: protocol for a hybrid type 1 effectiveness-implementation randomized wait-list controlled trial

ENABLE-SG（新加坡临终关怀教育、培育、指导）作为一种主动式姑息治疗模式：一项混合型1类有效性-实施随机等待名单对照试验方案

期刊:BMC Palliative Care
影响因子:3
doi:10.1186/s12904-024-01353-2
Ke, Yu; Cheung, Yin Bun; Bakitas, Marie; Odom, J Nicholas; Lum, Elaine; Tan, Daniel Shao Weng; Tan, Tira J; Finkelstein, Eric; Oh, Hong Choon; Zhou, Siqin; Yang, Grace Meijuan
发表日期：2024
文献求助 收藏

External validation of the first prognostic nomogram for older adults with cancer

对首个老年癌症患者预后列线图进行外部验证

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359231198433
Tay, Yu Ling; Ong, Whee Sze; Liew, Sherilyn Zi Hui; Chowdhury, Anupama Roy; Chan, Johan; Ramalingam, Mothi Babu; Rajasekaran, Tanujaa; Tan, Tira J; Krishna, Lalit; Lai, Olive; Chow, Agnes Lai Yin; Chen, Simon; Kanesvaran, Ravindran
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies

一项针对亚洲晚期或转移性恶性肿瘤患者，评估选择性核输出抑制剂 (SINE) selinexor 剂量递增后剂量扩展的安全性、药代动力学和药效学的 I 期研究

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359221087555
Ho, Jingshan; Heong, Valerie; Peng Yong, Wei; Soo, Ross; Ean Chee, Cheng; Wong, Andrea; Sundar, Raghav; Liang Thian, Yee; Gopinathan, Anil; Yan Pang, Mei; Koe, Priscillia; Nathan Jeraj, Santhiay; Pyar Soe, Phyu; Yar Soe, Mu; Tang, Tiffany; Ng, Matthew C H; Tai, David W M; Tan, Tira J Y; Xu, Hongmei; Chang, Hua; Landesman, Yosef; Shah, Jatin; Shacham, Sharon; Chin Lee, Soo; Tan, Daniel S W; Cher Goh, Boon; Tan, David S P
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas

GWN323（抗GITR）单药治疗以及与spartalizumab（抗PD-1）联合治疗晚期实体瘤和淋巴瘤患者的首次人体I/Ib期开放标签剂量递增研究

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-002863
Piha-Paul, Sarina A; Geva, Ravit; Tan, Tira J; Lim, Darren Wt; Hierro, Cinta; Doi, Toshikiko; Rahma, Osama; Lesokhin, Alexander; Luke, Jason John; Otero, Javier; Nardi, Lisa; Singh, Angad; Xyrafas, Alexandros; Chen, Xinhui; Mataraza, Jennifer; Bedard, Philippe L
淋巴瘤
PD-1
发表日期：2021
文献求助 收藏

Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center Experience

新加坡一项基于个体化分子谱分析的临床试验分配研究——亚洲三级癌症中心的经验

期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO.20.00261
Seet, Amanda O L; Tan, Aaron C; Tan, Tira J; Ng, Matthew C H; Tai, David W M; Lam, Justina Y C; Tan, Gek San; Gogna, Apoorva; Too, Chow Wei; Tan, Bien Soo; Takano, Angela; Lim, Alvin; Lim, Tse Hui; Lim, Soon Thye; Dent, Rebecca Alexandra; Ang, Mei Kim; Yap, Yoon-Sim; Tan, Iain B H; Choo, Su Pin; Toh, Chee Keong; Lim, Elaine H; Farid, Mohamad; Skanderup, Anders Jacobsen; Iyer, N Gopalakrishna; Lim, Wan Teck; Tan, Eng Huat; Lim, Tony K H; Tan, Daniel S W
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Novel therapeutic avenues in triple-negative breast cancer: PI3K/AKT inhibition, androgen receptor blockade, and beyond

三阴性乳腺癌的新型治疗途径：PI3K/AKT抑制、雄激素受体阻断及其他

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/1758835919880429
Chan, Jack J; Tan, Tira J Y; Dent, Rebecca A
肿瘤
肿瘤免疫
信号转导
乳腺癌
AKT
免疫/内分泌
发表日期：2019
文献求助 收藏